Otis (OTIS) Q2 2025 Earnings Call Transcript

Otis delivered mixed Q2 results: net sales were flat at $3.6 billion, adjusted operating margin held at 17%, and Service operating margin hit a record 24.9% with 4% organic growth, but New Equipment organic sales fell 11% and China orders declined more than 20%. Management raised the 2025 tariff headwind to just $25 million-$35 million from prior expectations, but trimmed net sales guidance to $14.5 billion-$14.6 billion while reaffirming adjusted EPS at $4.00-$4.10 and free cash flow at $1.4 billion-$1.5 billion. Share repurchases totaled about $550 million year-to-date, with a full-year target of $800 million.

Analysis

OTIS is quietly becoming a cash-compounding utility disguised as an industrial, and the market is likely underestimating how much the mix shift toward Service can cushion the uglier parts of New Equipment. The key second-order effect is that lower New Equipment volumes actually make the Service flywheel more valuable: a larger installed base, higher attachment, and more modernization touchpoints increase recurring revenue visibility while reducing cyclicality in the earnings stream. That creates a valuation floor, but it also means headline sales growth will stay structurally capped until China stops subtracting from mix.

The real swing factor is not this quarter’s margin print; it is whether North America backlog converts in 2H and into 2026. The company is signaling that order strength is real but revenue recognition is delayed by job-site friction, permitting, and macro hesitation — if that clears, there is a non-linear revenue catch-up because the booked pipeline is already there. Conversely, if trade uncertainty persists into year-end, OTIS risks a frustrating pattern of strong orders, weak revenue, and trapped working capital, which would keep the stock range-bound despite good EPS optics.

China is the cleaner contrarian angle. Consensus likely still treats it as a broad EM housing proxy, but management’s own language implies a bifurcated market: New Equipment is weak, while modernization and service are still expanding, supported by subsidized retrofit activity. That means China is less of a total earnings wipeout than it appears; the drag is increasingly about pricing and mix in New Equipment, not a wholesale collapse in demand, which should reduce downside tail risk versus typical cyclical industrials.

The biggest catalyst over the next 3-6 months is sequential improvement in 3Q/4Q service execution, followed by evidence that China orders have bottomed and North America revenue is starting to catch up to orders. If either shows up, OTIS can rerate as a high-quality compounder with a growing buyback yield; if not, the stock likely trades like a low-growth industrial with a good balance sheet but limited top-line torque. Tariff risk is real, but it is now mostly a second-half P&L issue, not a thesis killer.

Key Decisions for Investors

• Long OTIS on a 3-6 month horizon into 2H execution, targeting a rerating if Service growth re-accelerates and North America backlog starts converting; downside is limited by recurring cash generation and buybacks.
• Pair trade: long OTIS / short a more tariff-sensitive industrial with weaker recurring revenue (e.g., a capital-equipment peer) to isolate the resilience of service mix and reduce macro beta.
• Sell downside in OTIS via cash-secured puts 8-12% below spot expiring after the next two earnings cycles; thesis works if the market keeps over-penalizing near-term New Equipment weakness while ignoring buyback support.
• If China order stabilization is confirmed in the next quarter, add aggressively on any pullback: that is the cleanest catalyst for multiple expansion because it removes the last obvious bear case.
• Avoid chasing on a one-quarter EPS beat alone; wait for evidence of revenue conversion in North America, because that is the highest-conviction signal that 2026 estimates can move up materially.